English
中文简体
中文繁体
Company
Overview
Board of Directors
Partnering
Core competence
Technology
Bispecific
Proprietary ADC Platform
Mix-mAb
Publications
Pipeline
Overview
Envafolimab(KN035)
KN046
KN026
JSKN003
KN026+KN046
KN019
JSKN033
JSKN016
Investors
Information Disclosure
Corporate Governance
Stock Information
Corporate Communications
Email Subscription
News
Press Release
Media Report
Career
Corporate Culture
Job Opportunities
Contact Us
Company
Overview
Board of Directors
Partnering
Core competence
Technology
Bispecific
Proprietary ADC Platform
Mix-mAb
Publications
Pipeline
Overview
Envafolimab(KN035)
KN046
KN026
JSKN003
KN026+KN046
KN019
JSKN033
JSKN016
Investors
Information Disclosure
Corporate Governance
Stock Information
Corporate Communications
Email Subscription
News
Press Release
Media Report
Career
Corporate Culture
Job Opportunities
Contact Us
English
中文简体
中文繁体
Investors
Information Disclosure
Listing Documents
Financial Reports
Announcements & Circulars
Company Presentation
Corporate Governance
Stock Information
Corporate Communications
Email Subscription
Announcements & Circulars
The announcement begins in December 2019
INSIDE INFORMATION ANNOUNCEMENT - UPDATES IN RELATION TO A PHASE III CLINICAL TRIAL OF KN046 FOR THE TREATMENT OF ADVANCED PDAC
2023-11-14
VOLUNTARY ANNOUNCEMENT -UNUSUAL PRICE MOVEMENTS
2023-11-14
VOLUNTARY ANNOUNCEMENT - KN026 WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION BY THE NMPA
2023-11-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
2023-11-06
GRANT OF SHARE OPTIONS
2023-10-24
VOLUNTARY ANNOUNCEMENT - RESEARCH RESULTS ON KN046 AND KN026 PRESENTED AT ESMO CONGRESS 2023
2023-10-23
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
2023-10-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
2023-09-06
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
2023-08-23
VOLUNTARY ANNOUNCEMENT - RESEARCH UPDATES ON KN046 AND KN026 FOR PRESENTATION AT ESMO CONGRESS 2023
2023-08-10
1
2
3
4
5
6
PREV
3/22
NEXT